Skip to main content

Eye Health Supplements Market Technology Benefits, Manufacturing Processes by Applications 2019 to 2025

Global Eye Health Supplements Market is estimated to be valued at USD 9,355.09 Million by 2025 and is expected to register a CAGR of 6.36% during the forecast period 2019–2025.
The prevalence of ophthalmological disorders is growing at an alarming rate worldwide. An increasingly aging population and changing lifestyle are supporting the growing prevalence of ophthalmological disorders. 
Moreover, according to the National Eye Institute, about 3 million cases of pink eye (conjunctivitis) occur in the US each year. This rising prevalence of ophthalmological diseases and their related complications directly promote the growth of this market.
Key Players
Market Research Future (MRFR) recognizes Bausch & Lomb Incorporated, Alcon, Pfizer, Inc., NUSAPURE, Alliance Pharma PLC, Vitabiotics Ltd, Amway, Akorn Incorporated, EyeScience, Nordic Naturals, as the Key Players in the Global Eye Health Supplements Market.
Eye Health Supplements Market Segmentation
Global Market, by Indication
  • Age-Related Macular Degeneration (AMD)
  • Cataract
  • Glaucoma
  • Eye Fatigue
  • Corneal Support
  • Eyelid Conjunctivitis
  • Others
Global Market, by Product Type
  • Antioxidant
  • Neuro-Protective
  • Anti-Inflammatory
  • Others
Global Market, by Supplement Type
  • Vitamins
  • Minerals
  • Fatty Acids
  • Others
Global Market, by Form
  • Tablet/Capsule
  • Liquid
  • Gels
  • Gummies
  • Others
Global Market, by Distribution Channel
  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy
Key Findings of the Study
  • The Global Eye Health Supplements Market is projected to reach over USD 9,355.09 million by 2025 at a 6.36% CAGR during the review period of 2019 to 2025.
  • Based on indication, the age-related macular degeneration (AMD) segment accounted for the largest market share of 22.5% in 2018.
  • Based on product type, the antioxidant segment accounted for the largest market share of 38.6% in 2018.
  • Based on supplement type, the vitamins accounted for the largest market share of 42.7% in 2018.
  • Based on distribution channel, the online pharmacy segment accounted for the largest market share of 44.7% in 2018.
  • Key manufacturers in the eye health supplements market, such as Bausch & Lomb, Incorporated, Alcon, Pfizer, Inc., Amway, are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.
Global Market, by Region
  • America
    • North America
      • US
      • Canada
    • Latin America
  • Europe
    • Western Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa
About Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
+1 646 845 9312 | Email: sales@marketresearchfuture.com
Labels:

Comments

Post a Comment

Popular posts from this blog

Healthcare Analytics Market Emerging Trends and Technology Enhancements Research Report 2020

Healthcare Analytics Market Research Report: By Type (Predictive, Cognitive), Component (Software, Services), Delivery Model (On-Premise), Application (Financial Analytics, Clinical Analytics), End User (Payers, Hospitals)- Global Forecast till 2024 Healthcare Analytics Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report The report presents a detailed analysis of  Healthcare Analytics Market  by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current imp...
Post a Comment
Read more

3D Sewing Robots Market Technology Development, Growth Strategy, Top Players and Industry Trends with High CAGR by 2026

  3D Sewing Robots Market by Application (Clothes, Footwear, Home Décor, Bags & Fashion Accessories, Car Interiors, Others) and by Region (Americas [includes both North and South America], Europe, Asia Pacific), Global Trends and Forecast from 2019 to 2026 Global 3D Sewing Robots Market is expected to grow at more than 6.2% CAGR from 2019 to 2026. It is expected to reach above USD 135 million by 2026 from a little above USD 97 million in 2019.  This 3D Sewing Robots market research report discusses the key drivers influencing Automotive & Transportation market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The Research study also analyses key emerging trends and their impact on present and future development. Major Eminent players making significant moves in the global market have earned their reputation by launching various strategies and profiting:   PFAFF Industriesysteme und Maschinen Gmb...
Post a Comment
Read more

Krabbe Disease Treatment Market Set to Surge Significantly with New Innovations, Application, Recent Technology

  Krabbe Disease Treatment Market Overview Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the medicine is marketed. Increased government funding for drug development and easy approvals, tax credits on clinical research, reduction in the amount of registration fees also aid the growth of the market. These...
Post a Comment
Read more